Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $7,073.0M | $6,205.8M | $5,785.0M | $5,988.2M | $5,273.4M | $1,931.4M | $9,144.0M | $10.7B | $8,068.0M | $10.1B | $5,543.0M | $11.1B | $8,762.0M | $4,559.0M | $8,307.0M | $9,967.0M | $5,569.0M | $9,661.0M | $14.7B | $9,143.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Merck & Co., Inc.'s last 12-month Free Cash Flow is $14.8B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Merck & Co., Inc.'s Free Cash Flow growth was 12.7%. The average annual Free Cash Flow growth rates for Merck & Co., Inc. have been 31.6% over the past three years, 10.6% over the past five years.
Over the last year, Merck & Co., Inc.'s Free Cash Flow growth was 12.7%, which is higher than industry growth of (0.2%). It indicates that Merck & Co., Inc.'s Free Cash Flow growth is Good.